NF-κB inhibition delays DNA damage–induced senescence and aging in mice
Open accessThe DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Abstract
The accumulation of cellular damage, including DNA damage, is thought to contribute to aging-related degenerative changes, but how damage drives aging is unknown. XFE progeroid syndrome is a disease of accelerated aging caused by a defect in DNA repair. NF-κB, a transcription factor activated by cellular damage and stress, has increased activity with aging and aging-related chronic diseases. To determine whether NF-κB drives aging in response to the accumulation of spontaneous, endogenous DNA damage, we measured the activation of NF-κB in WT and progeroid model mice. As both WT and progeroid mice aged, NF-κB was activated stochastically in a variety of cell types. Genetic depletion of one allele of the p65 subunit of NF-κB or treatment with a pharmacological inhibitor of the NF-κB-activating kinase, IKK, delayed the age-related symptoms and pathologies of progeroid mice. Additionally, inhibition of NF-κB reduced oxidative DNA damage and stress and delayed cellular senescence. These results indicate that the mechanism by which DNA damage drives aging is due in part to NF-κB activation. IKK/NF-κB inhibitors are sufficient to attenuate this damage and could provide clinical benefit for degenerative changes associated with accelerated aging disorders and normal aging.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SASP inhibitors (senomorphics) can directly or indirectly attenuate the SASP of senescent cells by inhibiting transcription factor nuclear factor (NF)-κB, the JAK-STAT signal transduction pathway, the serine/threonine protein kinase mTOR, mitochondrial complex-1-related or 4-related targets, or other pathways involved in the induction and maintenance of the SASP103–106.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [104]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In vitro and in vivo, inhibitors of NF-κB (mediating the cell response to inflammation), can reduce pro-inflammatory SASP cytokines and chemokines104.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [104]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, removal of senescent cells promotes healthy aging in mice, making senescence‐associated inflammatory signaling an attractive target of therapeutic intervention for aging and age‐related disease (Tilstra et al, 2012; Childs et al, 2015; Baker et al, 2016; Ogrodnik et al, 2021).”
From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Tilstra et al, 2012
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“genetic and pharmacological inhibition of NF-κB signaling prevents age-associated features in different mouse models of accelerated aging”
From The Hallmarks of Aging (2013) · cites this paper as Tilstra et al., 2012
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Transcription factor enrichment analysis in Sen cells in all conditions revealed enrichment occupancy of key regulators of inflammation and the SASP, including NF-κB32, C/EBPβ33 and STAT1/3 (ref. 34), and of matrix remodelling/fibrosis, including SMAD3/4 (and inhibition of SMAD7)35 (Fig. 4c).”
From Senescence atlas reveals an aged-like inflamed niche that blunts muscle regeneration (2023) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A simple salting out procedure for extracting DNA from human nucleated cells
Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.3.1215 · Cited by 20,330 · cited 1×
“lated from mouse livers using a high-salt method (88) and analyzed for”
MethodShared Principles in NF-κB Signaling
Hayden, M. S., & Ghosh, S. (2008) · Cell · doi:10.1016/j.cell.2008.01.020 · Cited by 4,494
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290 · cited 1×
“In contrast to the results with rapamycin and our results with NBD, treatment with resveratrol and other SIRT agonists appears only able to extend healthspan and life span in mice on high-fat diets (76).”
ResultRapamycin fed late in life extends lifespan in genetically heterogeneous mice
Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., et al. (2009) · Nature · doi:10.1038/nature08221 · Cited by 3,766 · cited 1×
“The magnitude of the effect on healthspan elicited by NF-κB inhibition has only been observed in outbred mice treated with rapamycin (73), which targets the mTOR pathway, or by genetic deletion of S6K1, a downstream target of mTOR (74).”
BackgroundClearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
Premature ageing in mice expressing defective mitochondrial DNA polymerase
Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J. N., Rovio, A. T., Bruder, C. E., Bohlooly-Y, M., Gidlöf, S., Oldfors, A., Wibom, R., et al. (2004) · Nature · doi:10.1038/nature02517 · Cited by 2,734
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
Farrell, G. C., & Larter, C. Z. (2006) · Hepatology · doi:10.1002/hep.20973 · Cited by 2,414
Rejuvenation of aged progenitor cells by exposure to a young systemic environment
Conboy, I. M., Conboy, M. J., Wagers, A. J., Girma, E. R., Weissman, I. L., & Rando, T. A. (2005) · Nature · doi:10.1038/nature03260 · Cited by 2,287
The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway
Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D’Amico, M., Pestell, R., & Ben-Ze’ev, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5522 · Cited by 2,230
Research works printed but not linked: 3
- Tilstra, 2011, Aging Dis., 2, 449
- 10.1073/pnas.0704908104 · DOI · Paper page
- Tappel, 1973, Fed Proc., 32, 1870
Cited by
Items 101–200 of 478
Zhu, H., Li, X., Qiao, M., Sun, X., & Li, G. (2023) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glad009 · Cited by 92
NF-κB in Innate Neuroprotection and Age-Related Neurodegenerative Diseases
Lanzillotta, A., Porrini, V., Bellucci, A., Benarese, M., Branca, C., Parrella, E., Spano, P., & Pizzi, M. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00098 · Cited by 102
“Notably, Tilstra and colleagues demonstrated that RelA is the most contributing subunit in degenerative changes associated with senescence in a progeroid mice model (13).”
BackgroundWei, Z., Chen, X.-C., Song, Y., Pan, X.-D., Dai, X.-M., Zhang, J., Cui, X.-L., Wu, X.-L., & Zhu, Y.-G. (2016) · Chinese Medical Journal · doi:10.4103/0366-6999.186646 · Cited by 89
The Influence of Gut Microbiota on Neurogenesis: Evidence and Hopes
Sarubbo, F., Cavallucci, V., & Pani, G. (2022) · Cells · doi:10.3390/cells11030382 · Cited by 81
Measurement of oxidatively induced DNA damage and its repair, by mass spectrometric techniques
Dizdaroglu, M., Coskun, E., & Jaruga, P. (2015) · Free Radical Research · doi:10.3109/10715762.2015.1014814 · Cited by 88
Endothelial dysfunction in neuroprogressive disorders—causes and suggested treatments
Morris, G., Puri, B. K., OLIVE, L. S., Carvalho, A. F., Berk, M., Walder, K. R., Gustad, L. T., & Maes, M. H. J. (2020) · BMC Medicine · doi:10.1186/s12916-020-01749-w · Cited by 93
“This is a major driver of EC senescence and activation [307, 308], reviewed in [309].”
BackgroundZhang, L., Zhao, J., Mu, X., McGowan, S. J., Angelini, L., O'Kelly, R. D., Yousefzadeh, M. J., Sakamoto, A., Aversa, Z., LeBrasseur, N. K., et al. (2021) · Aging Cell · doi:10.1111/acel.13486 · Cited by 89
“We employed nuclear magnetic resonance (NMR) to determine body composition, including fat mass and lean tissue mass in Ercc1−/Δ mice (Tinsley et al., 2004).”
MethodSelf-citationNasto, L. A., Seo, H.-Y., Robinson, A. R., Tilstra, J. S., Clauson, C. L., Sowa, G., Ngo, K., Dong, Q. D., Pola, E., Lee, J. Y., et al. (2012) · Spine · doi:10.1097/brs.0b013e31824ee8f7 · Cited by 90
Self-citationBellucci, A., Bubacco, L., Longhena, F., Parrella, E., Faustini, G., Porrini, V., Bono, F., Missale, C., & Pizzi, M. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00068 · Cited by 84
“NF-κB has been reported to be essential for systemic and brain aging (Adler et al., 2008; Zhang et al., 2013), with RelA subunit mediating the most significant contribution to degenerative changes associated with senescence (Tilstra et al., 2012).”
BackgroundTissue-infiltrating macrophages mediate an exosome-based metabolic reprogramming upon DNA damage
Goulielmaki, E., Ιωαννίδου, Ά., Tsekrekou, M., Stratigi, K., Poutakidou, I. K., Gkirtzimanaki, K., Aivaliotis, M., Evangelou, K., Topalis, P., Altmüller, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13894-9 · Cited by 83
Self-citationMultiomics reveals glutathione metabolism as a driver of bimodality during stem cell aging
Benjamin, D. I., Brett, J. O., Both, P., Benjamin, J. S., Ishak, H. D., Kang, J., Kim, S., Chung, M., Arjona, M., Nutter, C. W., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.02.001 · Cited by 82
Cau, P., Navarro, C. L., Harhouri, K., Roll, P., Sigaudy, S., Kaspi, É., Perrin, S., Sandre‐Giovannoli, A. D., & Lévy, N. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.03.021 · Cited by 87
R-loops trigger the release of cytoplasmic ssDNAs leading to chronic inflammation upon DNA damage
Chatzidoukaki, O., Stratigi, K., Goulielmaki, E., Niotis, G., Akalestou-Clocher, A., Gkirtzimanaki, K., Zafeiropoulos, A., Altmüller, J., Topalis, P., & Garinis, G. A. (2021) · Science Advances · doi:10.1126/sciadv.abj5769 · Cited by 86
“We and others have recently shown that DNA damage–driven inflammation contributes substantially in NER progeria and age-related degenerative diseases, but the mechanisms remain unresolved ( 8 – 11 ).”
BackgroundSelf-citationSarubbo, F., Moranta, D., & Pani, G. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.05.011 · Cited by 80
Senescent cells as promising targets to tackle age-related diseases
Prašnikar, E., Borišek, J., & Perdih, A. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101251 · Cited by 73
Therapeutic targeting of senescent cells in the CNS
Riessland, M., Ximerakis, M., Jarjour, A. A., Zhang, B., & Orr, M. E. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01033-z · Cited by 77
“Conversely, inhibition of the binding between NF-κB and IKK, using a peptide inhibitor, ameliorated senescence in progeroid mice 153 .”
Shu, L., Zhang, H., Boyce, B. F., & Xing, L. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1938 · Cited by 80
“Aging is a complicated process associated with low‐grade chronic inflammation, including increased TNF levels((56,57)) and NF‐kB activity.((58)) Thus, it is likely that these factors upregulate Wwp1 expression, but this will require further investigation.”
BackgroundChanges in vitamin D endocrinology during aging in adults
de Jongh, R. T., van Schoor, N. M., & Lips, P. T. A. M. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.06.005 · Cited by 82
Functional conservation in genes and pathways linking ageing and immunity
Fabian, D. K., Fuentealba, M., Dönertaş, H. M., Partridge, L., & Thornton, J. M. (2021) · Immunity & Ageing · doi:10.1186/s12979-021-00232-1 · Cited by 81
The role of vitamin C in pushing back the boundaries of skin aging: An ultrasonographic approach
Crisan, D., Roman, I., Scharffetter-Kochanek, K., Crisan, M., & Badea, R. (2015) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s84903 · Cited by 73
“Both inflammation with enhanced release of ROS and pro-inflammatory cytokines like IL-1α and IL-1β among others promote dermal matrix degradation and constitute established molecular hallmarks of cutaneous aging.(9,10) The decrease in the natural cutaneous antioxidative mechanisms, overwhelmed by environmental and int…”
Comparison of mice with accelerated aging caused by distinct mechanisms
Gurkar, A. U., & Niedernhofer, L. J. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.01.045 · Cited by 70
Self-citationCell Senescence, Multiple Organelle Dysfunction and Atherosclerosis
Machado-Oliveira, G., Ramos, C., Marques, A. R. A., & Vieira, O. V. (2020) · Cells · doi:10.3390/cells9102146 · Cited by 80
The effects of age and systemic metabolism on anti-tumor T cell responses
Drijvers, J. M., Sharpe, A. H., & Haigis, M. C. (2020) · eLife · doi:10.7554/elife.62420 · Cited by 69
“…is similarly associated with aging – often referred to as ‘inflammaging’ (López-Otı́n et al., 2013), and this contributes to aging-related decline, as evidenced for example by the observation that inhibition of pro-inflammatory NF-kB signaling can reduce aging phenotypes (Tilstra et al., 2012).”
BackgroundNoncoding RNAs regulate NF-κB signaling to modulate blood vessel inflammation
Cheng, H. S., Njock, M.-S., Khyzha, N., Dang, L. T., & Fish, J. E. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00422 · Cited by 69
“Frontiers in Genetics | Genetics of Aging December 2014 | Volume 5 | Article 422 | 2 can delay aging (Osorio et al., 2012; Tilstra et al., 2012), demonstrating the key role that this signaling pathway plays in the aging process of various tissues.”
BackgroundGeroconversion of aged muscle stem cells under regenerative pressure
Sousa-Victor, P., Perdiguero, E., & Muñoz-Cánoves, P. (2014) · Cell Cycle · doi:10.4161/15384101.2014.965072 · Cited by 68
Khalil, R., Diab‐Assaf, M., & Lemaître, J.-M. (2023) · Cells · doi:10.3390/cells12060915 · Cited by 74
“Alternatively, it can be turned on by mTOR via an interaction with IKK [95] or in the DDR, as the ATM/NEMO complex is exposed to the cytoplasm, in which NEMO binds and enables the IKKα/β heterodimer.”
BackgroundInfluentialThe role of telomeres and vitamin D in cellular aging and age-related diseases
Pusceddu, I., Farrell, C.-J. L., Pierro, A. M. D., Jani, E., Herrmann, W., & Herrmann, M. (2015) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2014-1184 · Cited by 75
“The transcription factor NF-kB is a central component of the cellular response to damage, stress or inflammation [137].”
BackgroundNF-κB signaling as a driver of ageing
Osorio, F. G., Soria‐Valles, C., Santiago‐Fernández, O., Freije, J. M. P., & López-Otín, C. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.04.003 · Cited by 75
Zacca, E. R., Crespo, M. I., Acland, R. P., Roselli, E., Núñez, N. G., Maccioni, M., Maletto, B. A., Pistoresi-Palencia, M. C., & Morón, G. (2015) · PLOS ONE · doi:10.1371/journal.pone.0140672 · Cited by 66
Cellular Senescence in Aging Lungs and Diseases
Aghali, A., Ngassie, M. L. K., Pabelick, C. M., & Prakash, Y. S. (2022) · Cells · doi:10.3390/cells11111781 · Cited by 69
“Although upregulation of p16ink4a is meditated by the downstream signaling of p53-p21CIP1 [29,31,32,43,52], it is believed that the transcriptional factor p21CIP1 upregulates earlier than p16 ink4a [47], giving a chance for cultured cells to go for another division cycle before making it to a complete cell cycle arres…”
BackgroundInfluentialZhao, B., Wu, B. C., Feng, N., Zhang, X., Zhang, X., Wei, Y., & Zhang, W. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01426-4 · Cited by 81
“It is possible to use the so-called senomorphic drugs as the NF-κB-inhibiting drugs apigenin and kaempferol or the mTOR inhibitor rapamycin [380, 381], which can modify the SASP of senescent cells to become more responsive to checkpoint therapy clearance [382].”
BackgroundSu, T.-Y., Hauenstein, J., Somuncular, E., Dumral, Ö., Leonard, E., Gustafsson, C., Tzortzis, E., Forlani, A., Johansson, A., Qian, H., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52318-1 · Cited by 74
Zullo, A., Simone, E., Grimaldi, M., Musto, V., & Mancini, F. P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040928 · Cited by 69
Kim, D. E., Dollé, M. E. T., Vermeij, W. P., Gyenis, A., Vogel, K., Hoeijmakers, J. H. J., Wiley, C. D., Davalos, A. R., Hasty, P., Desprez, P., et al. (2020) · Aging Cell · doi:10.1111/acel.13072 · Cited by 64
“Several groups have described the presence of senescent cells in Ercc1−/Δ mice and suggested a role for these cells in accelerating aging phenotypes and pathologies when there is a defect in DNA damage repair (Robinson et al., 2018; Tilstra et al., 2012; Weeda et al., 1997).”
BackgroundBaker, J. R., Donnelly, L., & Barnes, P. J. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.01.027 · Cited by 69
Yan, J., Luo, A., Gao, J., Tang, X., Zhao, Y., Zhou, B., Zhou, Z., & Li, S. (2019) · Europe PMC (PubMed Central) · Cited by 75
Cellular Senescence and Senotherapies in the Kidney: Current Evidence and Future Directions
Docherty, M. H., Baird, D., Hughes, J., & Ferenbach, D. A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00755 · Cited by 69
“As is the case with genetic depletion, treated mice showed a delay in the onset of the majority of aging symptoms (Tilstra et al., 2012).”
BackgroundSchlett, J. S., Mettang, M., Skaf, A., Schweizer, P., Errerd, A., Mulugeta, E. A., Hein, T. M., Tsesmelis, K., Tsesmelis, M., Büttner, U. F. G., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00616-5 · Cited by 68
“Moreover, progeroid mouse models based on permanent genotoxic stress share an upregulation of NF-κB signaling [26, 27].”
BackgroundThe impact of astrocytic NF-κB on healthy and Alzheimer’s disease brains
Huat, T. J., Camats‐Perna, J., Newcombe, E. A., Onraet, T., Campbell, D., Sucic, J. T., Martini, A. C., Forner, S., Mirzaei, M., Poon, W. W., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-65248-1 · Cited by 74
Genetics of extreme human longevity to guide drug discovery for healthy ageing
Zhang, Z. D., Milman, S., Lin, J.-R., Wierbowski, S. D., Yu, H., Barzilai, N., Gorbunova, V. A., Ladiges, W., Niedernhofer, L. J., Suh, Y., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0247-0 · Cited by 67
Self-citationChen, H., Shi, B., Feng, X., Kong, W., Chen, W., Geng, L., Chen, J., Liu, R., Li, X., Chen, W., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39196 · Cited by 64
Dietary Phytochemicals in Neuroimmunoaging: A New Therapeutic Possibility for Humans?
Corbi, G., Conti, V., Davinelli, S., Scapagnini, G., Filippelli, A., & Ferrara, N. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00364 · Cited by 63
“SIRT1 could also protect against cellular senescence by inactivating NF-κ B (Rovillain et al., 2011; Tilstra et al., 2012) or deacetylating the FOXO3 transcription factor (Yao et al., 2012).”
BackgroundDNA Damage: From Chronic Inflammation to Age-Related Deterioration
Ιωαννίδου, Ά., Goulielmaki, E., & Garinis, G. A. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00187 · Cited by 71
Self-citationInnate immunosensing of DNA in cellular senescence
Glück, S., & Ablasser, A. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.09.013 · Cited by 66
Repurposing metformin to treat age-related neurodegenerative disorders and ischemic stroke
Sharma, S., Nozohouri, S., Vaidya, B., & Abbruscato, T. J. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119343 · Cited by 66
An, S., Cho, S.-Y., Kang, J., Lee, S., Kim, H.-S., Min, D.-J., Son, E., & Cho, K.-H. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1920338117 · Cited by 60
“Nuclear factor κB (NF-κB) activity is important for SASP, and suppression of NF-κB prevents age-related diseases and delays aging in mice (22, 23).”
BackgroundMolecular pathology endpoints useful for aging studies
Niedernhofer, L. J., Kirkland, J. L., & Ladiges, W. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.012 · Cited by 59
Self-citationPeriodontal Disease and Senescent Cells: New Players for an Old Oral Health Problem?
Aquino-Martínez, R., Khosla, S., Farr, J. N., & Monroe, D. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207441 · Cited by 66
“Consequently, NF-κB inhibition decreases oxidative stress DNA damage and delays the detrimental effects of cellular senescence in mice [144].”
BackgroundLiao, C., & Kennedy, B. K. (2014) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-397920-9.00003-2 · Cited by 62
“Genetic reduction in the level of the NF-kB subunit p65 (RelA) in Ercc1 / and Ercc1 /D mice delayed the onset of age-related pathology including muscle wasting, osteoporosis, and intervertebral disc degeneration (Tilstra et al., 2012).”
BackgroundWhat have we learned on aging from omics studies?
Cellerino, A., & Ori, A. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.06.012 · Cited by 61
DNA damage responses in ageing
da Silva, P. F. L., & Schumacher, B. (2019) · Open Biology · doi:10.1098/rsob.190168 · Cited by 55
“Overexpression of NF-κB is a known driving feature of ageing [129] and its inhibition delays cellular senescence and the onset of ageassociated features [130].”
BackgroundAstrocyte senescence and metabolic changes in response to HIV antiretroviral therapy drugs
Cohen, J., D’Agostino, L., Wilson, J., Tuzer, F., & Torres, C. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00281 · Cited by 58
“In addition, regions of the brain associated with high levels of glycolysis in healthy individuals correlate spatially with Aβ deposits in AD patients (Vlassenko et al., 2010).”
BackgroundLuteolin inhibits H 2 O 2 -induced cellular senescence via modulation of SIRT1 and p53
Zhu, R. Z., Li, B. S., Gao, S., Seo, J. H., & Choi, B. (2021) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2021.25.4.297 · Cited by 59
“There is a significantly increase in oxidative DNA damage in senescent cells, and the levels are similar to that seen in aging and age-related diseases [25,26].”
Translating the Biology of Aging into New Therapeutics for Alzheimer's Disease: Senolytics
Riessland, M., & Orr, M. E. (2023) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2023.104 · Cited by 52
“Interestingly, inhibition of the binding to IKK by using a peptide inhibitor reduced NF-kB activity and thereby senescence in progeroid mice (88).”
BackgroundDNA Damage Response and Metabolic Reprogramming in Health and Disease
Chatzidoukaki, O., Goulielmaki, E., Schumacher, B., & Garinis, G. A. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.06.018 · Cited by 62
Self-citationChen, Q., Tang, L., Zhang, Y., Wan, C., Yu, X., Dong, Y., Chen, X., Wang, X., Li, N., Xin, G., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2021.120089 · Cited by 62
Su, W., Liu, G., Mohajer, B., Wang, J., Shen, A., Zhang, W., Liu, B., Guermazi, A., Gao, P., Cao, X., et al. (2022) · eLife · doi:10.7554/elife.79773 · Cited by 54
Self-citationHaustead, D. J., Stevenson, A., Saxena, V., Marriage, F., Firth, M., Silla, R., Martin, L., Adcroft, K. F., Rea, S., Day, P. J., et al. (2016) · Scientific Reports · doi:10.1038/srep26846 · Cited by 59
Aging as a substrate of heart failure
Shioi, T., & Inuzuka, Y. (2012) · Journal of Cardiology · doi:10.1016/j.jjcc.2012.07.015 · Cited by 71
Zhang, W., Xu, M., Chen, F., Su, Y., Yu, M., Xing, L., Chang, Y. E., & Yan, T. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114474 · Cited by 60
DNA damage and its links to neuronal aging and degeneration
Delint‐Ramírez, I., & Madabhushi, R. (2025) · Neuron · doi:10.1016/j.neuron.2024.12.001 · Cited by 66
Mechanistic role of boswellic acids in Alzheimer’s disease: Emphasis on anti-inflammatory properties
Siddiqui, A., Shah, Z., Jahan, R. N., Othman, I., & Kumari, Y. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112250 · Cited by 59
Liu, Y., Shi, Y., Liu, Y., Pan, X., & Zhang, K. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0007-9 · Cited by 57
Stabilization of telomere by the antioxidant property of polyphenols: Anti-aging potential
Maleki, M., Khelghati, N., Alemi, F., Bazdar, M., Asemi, Z., Majidinia, M., Sadeghpoor, A., Mahmoodpoor, A., Jadidi‐Niaragh, F., Targhazeh, N., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118341 · Cited by 54
Inflammaging, cellular senescence, and cognitive aging after traumatic brain injury
Lu, Y., Jarrahi, A., Moore, N. D., Bartoli, M., Brann, D. W., Baban, B., & Dhandapani, K. M. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106090 · Cited by 54
“…sirtuin activators, mTOR activators, antioxidants, autophagy activators, and proteasome activators (Hubbard and Sinclair, 2014; Wei et al., 2017; Lamming et al., 2013; Chondrogianni et al., 2015; Tilstra et al., 2012; Xu et al., 2015b; Kang et al., 2017; Cao et al., 2011; Lee et al., 2016).”
BackgroundMicroRNAs, Long Non-Coding RNAs, and Circular RNAs in the Redox Control of Cell Senescence
Lettieri-Barbato, D., Aquilano, K., Punziano, C., Minopoli, G., & Faraonio, R. (2022) · Antioxidants · doi:10.3390/antiox11030480 · Cited by 51
Systemic DNA damage responses: organismal adaptations to genome instability
Ermolaeva, M. A., & Schumacher, B. (2014) · Trends in Genetics · doi:10.1016/j.tig.2013.12.001 · Cited by 50
“Likewise, some of the disease symptoms of XFE mice could be delayed by inhibiting NF-κB signaling [30].”
BackgroundAge-associated changes in the ecological niche: implications for mesenchymal stem cell aging
Asumda, F. Z. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt197 · Cited by 54
“and retards in vivo and in vitro senescence [110].”
BackgroundDNA double-strand breaks: a potential therapeutic target for neurodegenerative diseases
Thadathil, N., Hori, R. T., Xiao, J., & Khan, M. M. (2019) · Chromosome Research · doi:10.1007/s10577-019-09617-x · Cited by 55
Microglia-derived extracellular vesicles trigger age-related neurodegeneration upon DNA damage
Arvanitaki, E. S., Goulielmaki, E., Gkirtzimanaki, K., Niotis, G., Tsakani, E., Nenedaki, E., Rouska, I., Kefalogianni, M., Xydias, D., Kalafatakis, I., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2317402121 · Cited by 60
Self-citationNidadavolu, L. S., Niedernhofer, L. J., & Khan, S. A. (2013) · Aging · doi:10.18632/aging.100571 · Cited by 48
Self-citationMolecular pathology of rare progeroid diseases
Rieckher, M., Garinis, G. A., & Schumacher, B. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.06.011 · Cited by 54
Self-citationEisenman, S. T., Gibbons, S. J., Verhulst, P., Cipriani, G., Saur, D., & Farrugia, G. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12984 · Cited by 51
Aging modulates microglia phenotypes in neuroinflammation of MPTP-PD mice
Yao, K., & Zhao, Y. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.07.010 · Cited by 49
“Targeting NF-KB-p65 could reverse cellular senescence in vitro and in vivo (Tilstra et al., 2012).”
Hejazian, S. M., Hejazian, S. S., Mostafavi, S., Khatibi, S. M. H., Montazersaheb, S., Ardalan, M., Vahed, S. Z., & Barzegari, A. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01968-1 · Cited by 51
“A peptide with IKK-inhibiting features, the NF-κB-activating kinase, decreased cellular senescence [141].”
Mechanisms of arterial calcifications and consequences for cardiovascular function
London, G. M. (2013) · Kidney International Supplements · doi:10.1038/kisup.2013.92 · Cited by 55
“Senescence-associated secretory phenotype is linked to low-grade arterial inflammation with increased NFkB activation.(34) NF-kB activity, inflammation, and excessive production of reactive oxygen species are associated with several features of the progeroid syndrome such as accumulation of prelamin A,(35) low telomer…”
BackgroundJin, J., Tao, J., Gu, X., Yu, Z., Wang, R., Zuo, G., Li, Q., Lv, X., & Miao, D. (2017) · Scientific Reports · doi:10.1038/s41598-017-06868-8 · Cited by 47
RetractedPedret, A., Fernández‐Castillejo, S., Valls, R. M., Catalán, Ú., Rubió, L., Romeu, M., Macià, A., Hazas, M. L. D. L., Farràs, M., Giralt, M., et al. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800456 · Cited by 50
Mouse Models of Accelerated Cellular Senescence
Yousefzadeh, M. J., Melos, K. I., Angelini, L., Burd, C. E., Robbins, P. D., & Niedernhofer, L. J. (2019) · Methods in Molecular Biology · doi:10.1007/978-1-4939-8931-7_17 · Cited by 47
Self-citationMbara, K. C., Devnarain, N., & Owira, P. M. O. (2022) · Pharmaceutical Medicine · doi:10.1007/s40290-022-00444-w · Cited by 47
Chu, M., Sun, C., Chen, W., Jin, G., Gong, J., Zhu, M., Yuan, J., Dai, J., Wang, M., Pan, Y., et al. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.04.007 · Cited by 47
“KBIL1 is a member of the inhibitor of nuclear factor kappa B (NF) family (Greetham et al., 2007), which, activated by cellular mage and DNA double-strand break, also serves as the main gulator in the DNA damage response (Tilstra et al., 2012; Volcic al., 2012).”
BackgroundWang, H., Han, L., Zhao, G., Shen, H., Wang, P., Sun, Z., Xu, C., Su, Y., Li, G., Tong, T., et al. (2016) · Aging Cell · doi:10.1111/acel.12511 · Cited by 51
“D), which was opposite to our in vitro data and to the reported results that NF-jB activity is increased in multiple mammalian tissues during normal and premature aging (Adler et al., 2007; Tilstra et al., 2012; Zhang et al., 2013).”
ResultCheng, X. F., Yao, X., Xu, S., Pan, J., Yu, H., Bao, J., Guan, H., Lu, R., & Zhang, L. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.074 · Cited by 50
Molecular mechanisms and cardiovascular implications of cancer therapy-induced senescence
Abdelgawad, I. Y., Sadak, K. T., Lone, D. W., Dabour, M. S., Niedernhofer, L. J., & Zordoky, B. N. M. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107751 · Cited by 51
Self-citationFZD5 regulates cellular senescence in human mesenchymal stem/stromal cells
Harada, S., Mabuchi, Y., Kohyama, J., Shimojo, D., Suzuki, S., Kawamura, Y., Araki, D., Suyama, T. L., Kajikawa, M., Akazawa, C., et al. (2020) · Stem Cells · doi:10.1002/stem.3317 · Cited by 50
“cytokines, cell-to-cell contact, and dysregulation of intracellular signaling pathways, promote cell senescence.(26,27) Thus, the analysis of signals that affect human MSCs (hMSCs) may contribute to our”
BackgroundSelective anticancer agents suppress aging in Drosophila
Danilov, A., Shaposhnikov, M., Plyusnina, E., Kogan, V., Fedichev, P., & Moskalev, A. (2013) · Oncotarget · doi:10.18632/oncotarget.1272 · Cited by 45
Li, H., Luo, Y.-F., Wang, Y.-S., Yang, Q., Xiao, Y.-L., Cai, H.-R., & Xie, C.-M. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/9741838 · Cited by 45
“However, the overexpression of NF-κB subunit p65 induced cell senescence through genomic stability and DNA repair [29, 30], while the loss of p50, the suppressive heterodimer of p65, led to the accelerated prematurity of the cells [31].”
BackgroundSelf-citationThe role of cellular senescence in aging through the prism of Koch-like criteria
Yanai, H., & Fraifeld, V. E. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2017.10.004 · Cited by 45
Zheng, L., He, S., Wang, H., Li, J., Liu, Y., & Liu, S. (2024) · Aging and Disease · doi:10.14336/ad.2024.0206 · Cited by 83
“In Ercc1-/Δ mice, elimination of NF-κB-dependent SASP delays the onset of progeria-like symptoms and prolongs lifespan [77].”
Keeping zombies alive: The ER-mitochondria Ca2+ transfer in cellular senescence
Ahumada-Castro, U., Puebla-Huerta, A., Cuevas-Espinoza, V., Lovy, A., & Cárdenas, C. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119099 · Cited by 47
Age-Related Changes in the Fibroblastic Differon of the Dermis: Role in Skin Aging
Zorina, A. I., Zorin, V. L., Kudlay, D. A., & Kopnin, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116135 · Cited by 51
Baldisserotto, A., Vertuani, S., Bino, A., de Lucia, D., Lampronti, I., Milani, R., Gambari, R., & Manfredini, S. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.10.023 · Cited by 48
Development of novel NEMO-binding domain mimetics for inhibiting IKK/NF-κB activation
Zhao, J., Zhang, L. J., Mu, X., Doebelin, C., Nguyen, W., Wallace, C. T., Reay, D. P., McGowan, S. J., Corbo, L., Clemens, P. R., et al. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2004663 · Cited by 46
Self-citationSenotherapeutics and Their Molecular Mechanism for Improving Aging
Park, J., & Shin, D. W. (2022) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2022.114 · Cited by 49
“The 8K-NBD peptide, an inhibitor of NF-κB, decreased cellular senescence and attenuated age-related pathologies in Ercc1−/ Δ-progeroid mice (Tilstra et al., 2012).”
Gurkar, A. U., Robinson, A. R., Cui, Y., Li, X., Allani, S. K., Webster, A., Muravia, M., Fallahi, M., Weissbach, H., Robbins, P. D., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2018.06.005 · Cited by 45
Self-citationAl‐Azab, M., Wang, B., Elkhider, A., Walana, W., Li, W., Yuan, B., Ye, Y., Tang, Y., Almoiliqy, M., Adlat, S., et al. (2020) · Aging · doi:10.18632/aging.102958 · Cited by 46
The c-Rel Subunit of NF-κB Regulates Epidermal Homeostasis and Promotes Skin Fibrosis in Mice
Fullard, N., Moles, A., O’Reilly, S., van Laar, J. M., Faini, D., Diboll, J., Reynolds, N. J., Mann, D. A., Reichelt, J., & Oakley, F. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.02.016 · Cited by 49
“NF-kB is a critical regulator of inflammatory and proliferative responses in multiple organs and canonical NF-kB signaling is implicated in epidermal homeostasis, psoriasis,(3) skin wound healing responses, and aging.(29,30) However, the biological outcome of activating the NF-kB system can vary greatly, depending on…”
BackgroundYu, Y., Guerrero, C. R., Liu, S., Amato, N. J., Sharma, Y., Gupta, S. K., & Wang, Y. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.052696 · Cited by 45
Self-citationFang, J., Gao, L., Ma, H., Wu, Q., Wu, T., Wu, J., Wang, Q., & Cheng, F. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00747 · Cited by 45
“A recent study also showed that nuclear factor-kappa B (NF-kB) inhibition could delay the onset of aging symptoms in mice via reducing DNA damage (Tilstra et al., 2012).”
BackgroundDNA Damage-Mediated Neurotoxicity in Parkinson’s Disease
Wang, Z., Li, Y., Pu, J., & Zhang, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076313 · Cited by 46
Metadata
- Authors
- Tilstra, J. S., Robinson, A. R., Wang, J., Gregg, S. Q., Clauson, C. L., Reay, D. P., Nasto, L. A., St Croix, C. M., Usas, A., Vo, N., Huard, J., Clemens, P. R., Stolz, D. B., Guttridge, D. C., Watkins, S. C., Garinis, G. A., Wang, Y., Niedernhofer, L. J., & Robbins, P. D.
- Affiliations
- University of Pittsburgh (US)
- University of California, Riverside (US)
- Foundation for Research and Technology Hellas (GR)
- Scripps Research Institute (US)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2012-07-02
- Volume
- 122
- Issue
- 7
- Pages
- 2601-2612
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3386805
- OpenAlex
- W2116435487
- Cited by
- 462
- References
- 87
- Citations by year
- 2026: 30 · 2025: 30 · 2024: 33 · 2023: 34 · 2022: 43 · 2021: 37 · 2020: 39 · 2019: 26 · 2018: 37 · 2017: 23 · 2016: 30 · 2015: 36 · 2014: 26 · 2013: 26 · 2012: 11
- FWCI
- 10.29
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- D-Scholarship@Pitt (University of Pittsburgh) (acceptedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- Funders
- National Institute on Aging (R21AG033907, AG032816, AG 024827, R21AG033046, AG033907, AG-NS-0303-05, F30AG032816, AG033046, P30AG024827)
- National Cancer Institute (CA101864, CA103730, R01CA101864, P20CA103730, P30CA047904)
- National Institute of Environmental Health Sciences (R01ES019873, ES 016114, R01ES016114, ES019873)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR051456, R01AR051456)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- NF-κB, DNA damage, cellular senescence, aging, accelerated aging, DNA repair, IKK inhibition, p65 subunit, oxidative DNA damage, stress response, degenerative diseases
- MeSH terms
- Aging, Animals, Cell Nucleus, Cells, Cultured, DNA Damage, DNA-Binding Proteins, Endonucleases, Gene Expression Regulation, Mice, Transgenic, Peptides, Phosphorylation, Progeria, Protein Binding, Signal Transduction, Transcriptional Activation, Cellular Senescence, Oxidative Stress, Cyclin-Dependent Kinase Inhibitor p16, Hepatocytes, Mice, I-kappa B Kinase, Transcription Factor RelA
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.